Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, FL
Evaluate the efficacy of 2 oral dosing regimens of Fostamatinib Disodium (FosD) taken in combination with a disease-modifying anti-rheumatic drug (DMARD) in patients with active Rheumatoid Arthritis (RA)
Patient Inclusion Criteria:
- Active diagnosis of Rheumatoid Arthritis
- Treatment with 1 of the following traditional DMARDs: methotrexate, sulfasalazine, hydroxychloroquine or chloroquine
Patient Exclusion Criteria:
- Any systemic inflammatory conditions (other than RA), connective tissue disease or chronic pain disorders
- Uncontrolled hypertension
Patient Recruitment Team
Pharmax Research Clinic, Inc.
7200 NW 7th Street, Suite 350
Miami, FL 33126
Research Center Information: Pharmax Research Clinic, Inc.
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these